openPR Logo
Press release

Von Hippel-Lindau Market: New Study Offers Insights for 2020-2030 | Eli Lilly and Company, Bedford Laboratories, DNAtrix, Inc., Astellas US Holding, Inc.

03-05-2021 09:23 PM CET | Health & Medicine

Press release from: Fact.MR

Von Hippel-Lindau Market: New Study Offers Insights

Von Hippel-Lindau is an autosomal disease can cause malignant tumor due to the mutation in the Von Hippel-Lindau gene. Von Hippel-Lindau is one of the risk factor transmitted genetically that can cause cancer. The Von Hippel-Lindau disease effects 1 in 36,000 people in the world. The number of cases of Von Hippel-Lindau is about 10,000 in U.S. and more than 200,000 cases worldwide. About 97% of the symptoms of Von Hippel-Lindau disease will occur at the age of 65. The Von Hippel-Lindau disease occurs in all regions of the world. Von Hippel-Lindau affects both male and females equally. Patient who experienced Von Hippel-Lindau disease may also experience tumors and cysts. The tumors can occur in ten different parts of the body which includes kidney, brain, pancreas, eyes, spine, inner ears, adrenal glands, liver, lung and reproductive tract.

Request a report sample to gain valuable insights:

The Von Hippel-Lindau disease is different in every patient, even within the same family. Therefore it is very difficult to predict how and when the Von Hippel-Lindau disease will present in the individual. There is no drug available till date to cure the Von Hippel-Lindau disease. However the surgical removal is the only method to treat the Von Hippel-Lindau disease. Besides, early detection, careful monitoring and appropriate treatment can reduce the prevention of Von Hippel-Lindau disease. The diagnosis of Von Hippel-Lindau disease can be made by molecular genetic testing. When some changes or mutation in the Von Hippel-Lindau gene detected through genetic testing then the clinical diagnosis methods such as MRI and CT scan have been performed in order to detect the tumor position. The growing demand for advanced therapies, growing awareness about cancer, increasing healthcare expenditure and increasing number of tumor surgeries are expected to drive the Von Hippel-Lindau market growth over the forecast periods.

The Von Hippel-Lindau market can be segmented by tumor site, diagnosis, and end user.

Based on tumor site the Von Hippel-Lindau market can be segmented as

Adrenal Glands
Inner Ears
Reproductive Tract
Based on diagnosis the Von Hippel-Lindau market can be segmented as

MRI Scan
CT Scan
Based on the end user the Von Hippel-Lindau market can be segmented as

Diagnostic Centers
For More Detailed Information about Methodology:

Growing prevalence of Von Hippel-Lindau tumor and the growing awareness about cancer are the major factors expected to drive the growth of Von Hippel-Lindau market. Increasing number of surgeries for tumor treatment and development of advance therapies are also anticipated to accelerate the Von Hippel-Lindau market growth over forecast periods. Growing healthcare expenditure and increasing focus on research and development over the couple of years are also expected to boost the Von Hippel-Lindau market growth during forecast periods. However, no such availability of drugs and other medication to cure the Von Hippel-Lindau disease is also expected to hamper the market growth during forecast periods.

The global market of Von Hippel-Lindau is anticipated a huge growth during forecast periods owing to the increasing awareness towards the cancer treatment and growing research and development activities towards the development novel therapeutics to manage Von Hippel-Lindau disease. Increasing government funding for the healthcare research and development over the last few years is also anticipated to boost the global Von Hippel-Lindau market in upcoming years.

North America is expected to share high market value in Von Hippel-Lindau market owing to its growing research activities, increasing awareness of early diagnosis, and high research and development investments followed by Europe. Considerable market growth of Von Hippel-Lindau has also been expected from the Asia Pacific countries due to the increasing incidences of tumor and Von Hippel-Lindau disease. However, prominent growth of Von Hippel-Lindau market has been expected from the emerging countries such as China and India, in the forecast years. Moreover, the larger patient population and favorable government policies will provide a huge opportunity to the market players to develop and expand their product portfolio in Von Hippel-Lindau market in these regions.

Schedule a FREE Consultation Call with Our Analysts/Industry Experts to Find Solution for Your Business at 

Some of the major players operating in the Von Hippel-Lindau market are Eli Lilly and Company, Bedford Laboratories, DNAtrix, Inc., Astellas US Holding, Inc., Advantagene, Inc, Burzynski Research Institute, Inc., Cellectar Biosciences, Inc. and Direct Therapeutics, Inc. among others.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Von Hippel-Lindau Market: New Study Offers Insights for 2020-2030 | Eli Lilly and Company, Bedford Laboratories, DNAtrix, Inc., Astellas US Holding, Inc. here

News-ID: 2253119 • Views: 523

More Releases from Fact.MR

Automotive Mats Market: Needle-punched Designs will rake High Profits During For …
Automotive mats, also known as vehicle mats, are designed and manufactured to prevent the interior of vehicles from water, dirt and corrosion, safeguarding valuable investment of the customers. The demand for high-quality automotive mats, particularly in passenger vehicles, is gaining an uptick, with customers becoming more concerned about hygiene and aesthetics related to interior of their vehicles. Browse Full Report - With recent advancements in automotive fabric, adoption of nano-materials
Genetically Modified Organisms (GMO) Corn Market is poised to expand at a value …
Using genetic modification techniques and bioengineering procedures to cultivate crops is being commonly exercised across the global food and beverage industry. With global farming conditions getting worse, cultivation of crops such as maize (corn) is being heavily marred by irregular presence of key micronutrients such as dietary fibers. To get in-depth information view the report - Natural cultivation of corn, which is one of the richest source of energy (carbs) and has
Global CNG Vehicles Market to Expand at a CAGR of 3.2% Through 2027 | Ford Motor …
Fact.MR delivers key insights on the CNG vehicle market in its published report, titled “CNG vehicles: Industry Analysis and Opportunity Assessment, 2018–2027”. Click here to Get Complete Synopsis of the Report – In terms of revenue, the CNG vehicle market is estimated to expand at a CAGR of 3.2% over the forecast period, owing to the numerous factors, about which FACT.MR offers thorough insights and forecasts in this report.
North america expected to dominant regional market for release papers due to hig …
Release Papers Market: An Overview Release papers are coated with release-agents, serving wide applications such as safeguarding adhesive surfaces for tapes, labels, and other adhesive products. For each adhesive product, a release agent namely silicon is coated on the respective side of the base paper. This release papers are pre-coated, and with it is a barrier layer to avoid the soaking-in of release agent into the base paper. Release papers help

All 5 Releases

More Releases for Von

Von Willebrand Disease Treatment Market Trends, Outlook 2017-2025
Key players are organizing various symposiums to raise awareness about von Willebrand Disease and to increase brand visibility. Key players in von Willebrand Disease (vWD) treatment market include Octapharma, Shire Plc, BDI Pharma, Baxalta, Ferring Pharmaceuticals, CSL Behring, and Grifols Therapeutics Inc. In 2017, Octapharma organized a symposium at the International Society on Thrombosis and Haemostasis (ISTH) congress in Berlin to support progress in lifelong treatment for patients with von Willebrand Disease
Von Willebrand Disease Pipeline Insight Report 2017- Market Research Hub
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Von Willebrand Disease-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Von Willebrand Disease. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Von Willebrand Disease by development stage, therapy type,
Ein Hauch von China in Berlin Mitte
Startup-Business von Peking nach Berlin Es ist Freitagabend, 19 Uhr in Peking. Genauer: in Zhongguancun, dem High-Tech-Mekka Asiens. Auch die fleißigsten Unternehmer im Silicon Valley Chinas, wie das Viertel im Pekinger Stadtteil Haidian oft genannt wird, freuen sich auf das bevorstehende Wochenende und auf ein wenig Abstand von der Arbeit. Zumindest auf den räumlichen Switch in die eigenen vier Wände und das heimische Sofa. Auch die junge Chinesin und Techcode-Mitarbeiterin Li Na
05-10-2016 | Health & Medicine
Die Anwendung von Fischhaut beschleunigt die Heilung von offenen, schwer heilbar …
„High-Impact“-Studien, die Kerecis auf einer großen europäischen Wundkonferenz präsentiert, zeigen beschleunigte und verbesserte Heilung der Wunden Bremen, 09. Mai 2016 – Kerecis, das Unternehmen, das mit Omega-3-reicher Fischhaut menschliche Wunden und Gewebeschäden heilt, präsentiert vom 11. bis 13. Mai auf dem European Wound Management Symposium (EWMA) in Bremen Ergebnisse von in vivo und in vitro durchgeführten Versuchen. Der Austellungsplatz von Kerecis findet sich am Stand 1A 05. In einer Studie führte die
Friederike von Rauch’s exhibition In Secret presents a selection of her photographs from different series produced between 2010 and 2013: focused and picturesque compositions of light and shade that elevate unremarkable architectural details to the status of stand-alone subjects and question our habits of perception. The works were created in various European museums and post-war modernist churches. Following her training as a silversmith, Friederike von Rauch studied Industrial Design at
Koreans love "Princess Maja von Hohenzollern" - designs
Baby- bath- line "STyLE! Princess" designed by Princess Maja von Hohenzollern on the road to succcess in Korea. The charming baby bath line "STyLE! Princess" in delicate pink and elegant silver-gray, has been designed by Princess Maja Princess of Hohenzollern for little princes & princesses. The cute baby bath line is also among the Koreans in great favor. The "Guhee Corporation" is selling the "Princess Style-Line" at consumer fairs and throughout